Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period

Vaccine

Volumn 28, Issue 20, 2010, Pages 3558-3562

  Rizzo, Caterina ^a   Rota, Maria Cristina ^a   Bella, Antonino ^a   Alfonsi, Valeria ^a   Declich, Silvia ^a   Caporali, Maria Grazia ^a   Ranghiasci, Alessia ^a   Lapini, Giulia ^b   Piccirella, Simona ^b   Salmaso, Stefania ^a   Montomoli, Emanuele ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Italy; Pandemic influenza; Seroprevalence

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ASSAY; BLOOD SAMPLING; CHILD; CROSS REACTION; FEMALE; GENDER; GEOGRAPHIC PATHOLOGY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFANT; INFLUENZA VIRUS A H1N1; ITALY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SERODIAGNOSIS; SEROPREVALENCE; SINGLE RADIAL HAEMOLYSIS ASSAY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; CROSS-SECTIONAL STUDIES; FEMALE; GEOGRAPHY; HEMAGGLUTINATION INHIBITION TESTS; HEMOLYSIS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; ITALY; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 77950595238     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.006     Document Type: Article

References (23)

1. Miller M.A., Viboud C., Balinska M., and Simonsen L. The signature features of influenza pandemics-implications for policy. N Engl J Med 360 June (25) (2009) 2595-2598
2. Rizzo C., Bella A., Viboud C., Simonsen L., Miller M.A., Rota M.C., et al. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerg Infect Dis 13 May (5) (2007) 694-699
3. Coker R. Swine flu. BMJ 338 (2009) b1791
4. Michaelis M., Doerr H.W., and Cinatl Jr. J. An influenza A H1N1 virus revival-pandemic H1N1/09 virus. Infection September (2009)
5. Scholtissek C., von H.V., and Rott R. Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology 89 September (2) (1978) 613-617
6. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460 August (7258) (2009) 1021-1025
7. Neumann G., Noda T., and Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459 June (7249) (2009) 931-939
8. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325 July (5937) (2009) 197-201
9. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morb Mortal Wkly Rep 58 May (19) (2009) 521-524
10. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med September (2009)
11. Greenberg M.E., Lai M.H., Hartel G.F., Wichems C.H., Gittleson C., Bennet J., et al. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine-preliminary report. N Engl J Med September (2009)
12. WHO. WHO biological standards. WHO; 2009. Available from: URL: http://www.who.int/biologicals/en/.
13. EMEA. Note for Guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP 214/96; 1996. Ref Type: Generic.
14. Ellis J.S., and Zambon M.C. Molecular analysis of an outbreak of influenza in the United Kingdom. Eur J Epidemiol 13 June (4) (1997) 369-372
15. Schild G.C., Pereira M.S., and Chakraverty P. Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ 52 1 (1975) 43-50
16. European Committee for Medicinal Products for Human Use (CHMP). Guidelines on influenza vaccines prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context. EMEA/CHMP/VWP/263499/2006; 2007. Ref Type: Generic.
17. WHO. WHO manual on animal influenza diagnosis and surveillance. WHO/CDS/CSR/NCS/2002.5 Rev.1; 2002. Ref Type: Generic.
18. Meguro H., Bryant J.D., Torrence A.E., and Wright P.F. Canine kidney cell line for isolation of respiratory viruses. J Clin Microbiol 9 February (2) (1979) 175-179
19. Reed L.J., and Muench H. A simple method of estimating fifty per cent endpoint. Am J Hyg 27 (1938) 493-497 Ref Type: Generic
20. Miller E., Hoschler K., Hardelid P., Stanford E., Andrews N., and Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet January (2010)
21. Ikonen N., Kinnunen L., Österlund P., Pirhonen J., Broman M., Davidkin I., et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 15 5 (2010) pii = 19478
22. Cnesps-ISS. FLUNEWS. http://wwwepicentroissit/focus/h1n1/archivioflunewsasp; 2010.
23. Ministry of Health. http://wwwnuovainfluenzasalutegovit/nuovainfluenza/archivioOrdinanzeCircolariNuovaInfluenza jsp 2010.